RESUMO
A minority of individuals infected with the parasite Schistosoma mansoni develops hepatic fibrosis. HLA studies in Egypt and a candidate gene search in a Sudanese population indicate that the host's genetics contribute to disease susceptibility. In an Egyptian community, 32.7% of individuals 11 years and older had significant fibrosis by WHO ultrasound criteria. Linkage to 10 candidate genes was tested using 89 affected sibling pairs from 40 pedigrees in this community. The candidates included genes that initiate fibrosis, participate in collagen synthesis, or control collagen degradation. Two to four single-nucleotide polymorphisms (SNPs) were genotyped per locus, and 188 individuals were genotyped at 48 markers. Model-free modified Haseman-Elston analysis identified linkage to a SNP in the interferon gamma receptor locus (P=0.000001). There was also weak evidence for linkage to the interleukin 13-4 region and tissue growth factor beta 1.
Assuntos
Ligação Genética , Cirrose Hepática/parasitologia , Hepatopatias Parasitárias/complicações , Receptores de Interferon/genética , Esquistossomose mansoni/complicações , Adolescente , Adulto , Egito , Feminino , Marcadores Genéticos , Predisposição Genética para Doença , Humanos , Interleucina-13/genética , Cirrose Hepática/diagnóstico por imagem , Cirrose Hepática/genética , Hepatopatias Parasitárias/diagnóstico por imagem , Hepatopatias Parasitárias/genética , Hepatopatias Parasitárias/parasitologia , Masculino , Linhagem , Polimorfismo de Nucleotídeo Único , Esquistossomose mansoni/diagnóstico por imagem , Esquistossomose mansoni/genética , Esquistossomose mansoni/parasitologia , Ultrassonografia , Receptor de Interferon gamaRESUMO
BACKGROUND: Nitric oxide (NO) is produced by a group of synthase enzymes (NOS). By means of different pathways, NO exerts several functions in benign and malignant human bladder tissues. The current paper describes the NO/guanylate cyclase (sGC)/cyclic guanosine monophosphate (cGMP) and the NO/oxidative pathways in human bladder tissues. METHODS: Bladder carcinoma tissues were collected from 18 patients by transurethral resection procedures. Normal benign vesical tissue specimens from a further eight patients with benign diseases served as controls. Immunohistochemistry was conducted for localization of sGC, cGMP, and nitrotyrosine in benign and malignant vesical tissues, evaluating two-three tissue sections per patient. RESULTS: Positive immunolabeling for sGC and cGMP was detected in vascular endothelial cells of normal and malignant vesical tissues. Those signals were most intense in bladder carcinoma tissues. Immunolabeling for sGC and cGMP was also detected in normal urothelial cells. In bladder carcinoma cells, a heterogeneous immunolabeling for sGC and cGMP was seen, with a wide spectrum of signal intensity. Positive immunostaining for sGC and cGMP was also observed in stromal round cells in benign and malignant bladder tissues. Immunolabeling for nitrotyrosine was mainly observed in endothelial cells, with a much stronger immunolabeling in bladder carcinoma tissues compared to normal benign controls. A weak immunolabeling for nitrotyrosine was also observed in bladder carcinoma cells. Normal urothelial cells did not show such nitrotyrosine expression. CONCLUSIONS: The current report provides evidences that NO play several roles through different pathways in benign and malignant vesical tissues. The influences generated by NO molecules can be divided into cGMP-mediated effects (those resulting from the NO/sGC/cGMP pathway) and non-cGMP-mediated effects (those resulting from the NO/oxidative pathway). Increased angiogenesis is a cGMP-mediated effect, while nitrotyrosine production is a non cGMP-mediated oxidative effect. Such an NO/oxidative pathway is observed more often in bladder carcinoma.
Assuntos
Carcinoma/fisiopatologia , GMP Cíclico/farmacologia , Sequestradores de Radicais Livres/farmacologia , Guanilato Ciclase/farmacologia , Óxido Nítrico Sintase/farmacologia , Óxido Nítrico/farmacologia , Tirosina/análogos & derivados , Tirosina/farmacologia , Neoplasias da Bexiga Urinária/fisiopatologia , Idoso , Western Blotting , Carcinoma/enzimologia , Transformação Celular Neoplásica , Humanos , Imuno-Histoquímica , Neovascularização Patológica , Óxido Nítrico Sintase/análise , Oxirredução , Neoplasias da Bexiga Urinária/enzimologiaRESUMO
Urothelial carcinoma with choriocarcinomatous features is a rare malignancy arising in the urinary bladder or renal pelvis. We report the case of a 60-year-old man with a biphasic neoplasm of the right kidney composed of papillary urothelial carcinoma and choriocarcinoma. Widespread hepatic and pulmonary metastases with choriocarcinomatous features were found on autopsy 6 weeks after initial diagnosis. Chromosomal analysis revealed a close genetic relationship between the papillary urothelial and choriocarcinomatous tumor components, documenting for the first time that choriocarcinoma of the renal pelvis results from clonal evolution of urothelial carcinoma with acquisition of trophoblastic differentiation.